This topic contains a solution. Click here to go to the answer

Author Question: A chronic and severely debilitating condition that results in high medical costs and long-term ... (Read 120 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
A chronic and severely debilitating condition that results in high medical costs and long-term dependence on the health care system is called a(n):
 
  a. chronic illness
  b. episodic illness
  c. catastrophic illness
  d. categorical illness

Question 2

Structural discrimination is:
 
  a. Bias against disabled persons through architectural standards.
  b. A series of factors that negatively impinge on specific groups.
  c. An unfair preference for a theoretical approach.
  d. A bias against different populations.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

juiceman1987

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

c

Answer to Question 2

B




Alygatorr01285

  • Member
  • Posts: 564
Reply 2 on: Jul 2, 2018
Thanks for the timely response, appreciate it


Liamb2179

  • Member
  • Posts: 365
Reply 3 on: Yesterday
Excellent

 

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

A seasonal flu vaccine is the best way to reduce the chances you will get seasonal influenza and spread it to others.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

To maintain good kidney function, you should drink at least 3 quarts of water daily. Water dilutes urine and helps prevent concentrations of salts and minerals that can lead to kidney stone formation. Chronic dehydration is a major contributor to the development of kidney stones.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library